Metformin-Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention.
Аннотация
INTRODUCTION
Metformin, the common anti-hyperglycemic agent, is emerging with pharmacological significance as an effective anti-cancer modulator. Its efficacy as an anti-cancer modulator is reported in pre-clinical and clinical studies. Therefore, an attempt was made to identify the possible in vitro anti-cancer molecular mechanisms studied on breast cancer (BC) cell lines.
METHODS
An advanced literature search was conducted in the PubMed database using search terms "Metformin, Cell culture, Breast neoplasms." Different anti-cancer molecular mechanisms induced by metformin (MET) identified in cell culture studies are presented in this paper.
RESULTS
It was identified that MET induces molecular pathways that exert anti-cancer effects when treated on BC cells. Inhibition of oxidative phosphorylation, adenosine monophosphate-activated protein kinase mediated anticancer effects, anti-proliferation and inhibition of cell migration, alteration of tumor micro-environment, synergetic effects with conventional chemotherapies and other potential molecules, induced apoptosis and ferroptosis were mainly identified as MET-induced pathways that affect BC cells.
CONCLUSION
Metformin induces diverse anti-cancer biochemical pathways through which it exhibits a potential to be used as an anti-cancer therapeutic in BC.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.